Short answer: This article explains the key facts, eligibility issues, settlement factors, deadlines, and source-backed updates related to this legal topic. Results vary by case facts, evidence, jurisdiction, and representation.
Depo-Provera Lawsuit Texas 2026: Eligibility, Deadlines and How to File
If you live in Texas and developed an intracranial meningioma after receiving Depo-Provera or a generic depot medroxyprogesterone acetate injection, a Depo-Provera Lawsuit Texas review may help determine whether you can join the federal litigation.
This Texas-focused guide explains how MDL No. 3140 works, how Texas filing deadlines may apply, what records attorneys review, and how a Depo-Provera Lawsuit Texas claim may be evaluated for settlement purposes.
Quick Answer: Depo-Provera Lawsuit Texas
A Depo-Provera Lawsuit Texas claim generally involves a Texas resident who received Depo-Provera or generic depot medroxyprogesterone acetate and was later diagnosed with an intracranial meningioma. The official MDL page identifies MDL No. 3140 in the Northern District of Florida and describes allegations that Depo-Provera or generic equivalents can cause users to develop meningiomas.
- Core injury: Intracranial meningioma after Depo-Provera or generic DMPA use.
- Texas deadline issue: Texas generally uses a two-year personal injury limitations period, but discovery issues can matter.
- Federal court: Many claims are coordinated in MDL No. 3140 before Judge M. Casey Rodgers.
- Important hearing: The federal court lists a Rule 702 motions hearing for June 24–26, 2026.
- Claim documents: Injection records, imaging reports, pathology, treatment records, and diagnosis timelines.
- Free review: A Depo-Provera Lawsuit Texas attorney review can check exposure, diagnosis, deadlines, and case value factors.
Depo-Provera Lawsuit Texas Overview
The Depo-Provera Lawsuit Texas topic is important because Texas residents may have both federal MDL issues and Texas-specific filing questions. The federal proceeding coordinates discovery, expert challenges, case management, and bellwether preparation, but a Texas claimant’s filing deadline, damages proof, medical records, and personal history still matter.
Depo-Provera is an injectable contraceptive containing medroxyprogesterone acetate. Plaintiffs in the federal litigation allege that long-term or repeated use may increase the risk of meningioma, a tumor that develops from the membranes surrounding the brain and spinal cord. Defendants dispute liability, causation, and other claims, which is why expert evidence is central to the case.
A Depo-Provera Lawsuit Texas review is not the same as a class action signup. Most mass tort claimants need individualized records showing their injection history, medical diagnosis, treatment, damages, and timing. Texas residents should not assume that simply living in Texas protects their deadline; state law and discovery facts must be reviewed quickly.
Who May Qualify for a Depo-Provera Lawsuit in Texas?
Eligibility for a Depo-Provera Lawsuit Texas claim depends on medical and prescription evidence. A claimant usually needs documented Depo-Provera or generic DMPA exposure and a later meningioma diagnosis. The strongest claims often have repeated injections, clear diagnosis records, and symptoms or treatment that show meaningful harm.
Injection History
Attorneys look for pharmacy records, clinic records, OB-GYN records, Medicaid records, or other proof showing Depo-Provera or generic DMPA injections.
Meningioma Diagnosis
MRI, CT, pathology, neurology, neurosurgery, radiation, monitoring, and hospital records can document the meningioma diagnosis and treatment course.
Deadline Review
Texas limitations rules may depend on diagnosis date, discovery date, warning awareness, and individual medical facts. Do not wait to request review.
A person who did not have surgery may still request a Depo-Provera Lawsuit Texas evaluation if she has a confirmed meningioma diagnosis. Surgery can affect damages, but it is not the only factor. Watchful waiting, radiation, recurring scans, lost income, cognitive changes, vision issues, seizures, and quality-of-life effects may also matter.
For a broader eligibility checklist, review TortAdvisor’s Depo-Provera eligibility guide and compare your facts with the main Depo-Provera lawsuit overview.
Texas Statute of Limitations for Depo-Provera Claims
A Depo-Provera Lawsuit Texas deadline can be complicated. Texas Civil Practice and Remedies Code Section 16.003 generally gives a two-year period for personal injury claims. In latent injury cases, however, plaintiffs often need a careful discovery-rule analysis to determine when the claim accrued.
That means the relevant date may not be as simple as the first injection date. A lawyer may review when the meningioma was diagnosed, when the claimant learned or reasonably should have learned of a potential connection to Depo-Provera, and whether medical records or warnings affected discovery. Because these issues are fact-sensitive, Texas residents should get a deadline review immediately.
How Texas Claims Fit Into MDL No. 3140
A Depo-Provera Lawsuit Texas claim may be filed or transferred into the federal MDL for coordinated pretrial proceedings. MDL centralization does not mean every claimant receives the same outcome. Instead, the process can streamline discovery, expert motions, common evidence, pretrial orders, and bellwether trial planning.
The Northern District of Florida’s MDL page lists the case as In Re: Depo-Provera Products Liability Litigation, MDL No. 3140. The court also lists important hearing dates, including the June 24–26, 2026 Rule 702 motions hearing. Rule 702 governs expert testimony, making the hearing especially important for causation evidence.
For Texas claimants, the MDL process may decide common scientific and procedural issues, while individual facts remain important. If no global settlement occurs, cases can proceed through later stages based on venue, trial selection, remand, or other court orders. A Depo-Provera Lawsuit Texas lawyer can explain how a Texas claim may be filed, transferred, tolled, or otherwise preserved.
Depo-Provera Lawsuit Texas Settlement Value Factors
No global settlement has been announced for MDL No. 3140. A Depo-Provera Lawsuit Texas settlement estimate therefore should be treated as educational, not guaranteed. The value of any claim depends on injury severity, proof of injections, timing, medical treatment, economic losses, and litigation developments.
| Claim Factor | Why It Matters | Examples of Helpful Proof |
|---|---|---|
| Exposure | Repeated or long-term DMPA exposure may support causation arguments. | Clinic records, pharmacy records, OB-GYN notes, Medicaid records. |
| Diagnosis | Meningioma confirmation is central to the claim. | MRI, CT, pathology, neurology, neurosurgery records. |
| Treatment | Surgery, radiation, monitoring, or neurological symptoms can affect damages. | Hospital bills, procedure notes, scan history, specialist reports. |
| Texas damages | Lost wages, medical bills, pain, suffering, and long-term care can affect value. | Pay records, bills, insurance records, caregiver records. |
Use TortAdvisor’s settlement calculator hub for an educational estimate, then compare it with the Depo-Provera settlement amounts guide. A Depo-Provera Lawsuit Texas claim should still be reviewed by an attorney before any settlement range is relied on.
How to File a Depo-Provera Lawsuit Texas Claim
To start a Depo-Provera Lawsuit Texas review, gather your injection records, diagnosis records, and treatment timeline. You do not need to travel to Florida to ask whether your facts may qualify. A legal intake can begin with basic information about where you received injections, when your meningioma was diagnosed, and what treatment you received.
- Request a free review: Call 1 (855) 731-2894 or use the TortAdvisor intake process.
- Confirm injection history: Identify clinics, doctors, pharmacies, insurance records, or Medicaid records.
- Confirm diagnosis: Locate MRI, CT, neurology, pathology, or neurosurgery documents.
- Check Texas deadlines: Review diagnosis date, discovery date, and state-law deadline issues.
- Preserve the claim: If eligible, counsel can explain filing in or coordination with MDL No. 3140.
Because the Depo-Provera Lawsuit Texas process involves both federal coordination and Texas-specific facts, the safest approach is to request a review before the deadline becomes disputed.
Depo-Provera Lawsuit Texas FAQ
Can Texas residents join the federal Depo-Provera MDL?
Yes. A Texas resident may be eligible for federal MDL coordination if the claim involves Depo-Provera or generic DMPA exposure and a later meningioma diagnosis. A Depo-Provera Lawsuit Texas review should also evaluate Texas filing deadlines.
What is the Texas deadline for filing?
Texas generally has a two-year personal injury limitations period, but latent-injury discovery facts can affect the analysis. Do not rely on a general online deadline; ask for a claim-specific Depo-Provera Lawsuit Texas review.
Do I need surgery to qualify?
No. Surgery can increase damages in some cases, but people with confirmed meningiomas managed through monitoring, medication, or radiation may still request review.
How many cases are pending?
Public trackers reported roughly 5,508 pending MDL cases in June 2026. Official court and JPML figures can update monthly, so any case-count statement should be checked before publication.
What records should I collect?
Collect injection records, diagnosis records, imaging, pathology, surgical records, bills, lost-income documents, and the names of doctors or clinics that treated you.
Is a Depo-Provera Lawsuit Texas claim guaranteed to settle?
No. No settlement is guaranteed. The value and outcome of any Depo-Provera Lawsuit Texas claim depends on evidence, expert rulings, defenses, individual damages, and negotiations.
Sources and Citations
These sources support the MDL schedule, Texas limitations discussion, FDA label context, and medical-science background discussed in this Depo-Provera Lawsuit Texas guide.
- U.S. District Court, Northern District of Florida — Depo-Provera Products Liability Litigation, MDL No. 3140
- U.S. District Court, Northern District of Florida — Important Hearing Dates and Rule 702 Motions Hearing
- U.S. District Court, Northern District of Florida — MDL No. 3140 Orders by Date
- Texas Civil Practice and Remedies Code Section 16.003
- FDA Prescribing Information — Depo-Provera / Medroxyprogesterone Acetate Meningioma Warning
- PubMed — Depot Medroxyprogesterone Acetate and Risk of Meningioma
- MDL Update — June 2026 Depo-Provera Case Count Tracker
Request a Free Depo-Provera Lawsuit Texas Review
If you were diagnosed with meningioma after Depo-Provera or generic DMPA injections, do not wait to check your Texas deadline. A confidential Depo-Provera Lawsuit Texas review can help evaluate records, timing, eligibility, and possible next steps.
Related Posts
Discover what is SSI: eligibility, benefits, application process, SSI vs SSDI, and FAQs for low-income aged, blind, disabled.
Decades of scientific research, the IARC's 2024 Group 1 carcinogen reclassification, and J&J's failed bankruptcy attempts have reshaped the talcum powder lawsuit landscape in 2026. Learn what the science says, who qualifies, what settlements look like, and how to file a claim.
How to File a Snapchat Lawsuit 2026 If your child was sexually exploited, groomed, sextorted, or harmed on Snapchat, [...]
